Is Editas Medicine Inc (NASDAQ: EDIT) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

EDIT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Editas Medicine Inc is $439.16M. A total of 1.11 million shares were traded on the day, compared to an average of 2.12M shares.

In the most recent transaction, Mei Baisong sold 6,619 shares of EDIT for 5.21 per share on Jul 19 ’24. After the transaction, the EVP, CHIEF MEDICAL OFFICER now owns 134,413 company shares. In a previous transaction on Jun 04 ’24, O’Neill Gilmore Neil sold 12,191 shares at 5.50 per share. EDIT shares that CEO owns now total 315,279.

Among the insiders who sold shares, Mei Baisong disposed of 511 shares on Jun 04 ’24 at a per-share price of $5.50. This resulted in the EVP, CHIEF MEDICAL OFFICER holding 141,032 shares of EDIT after the transaction. In another insider transaction, Lucera Erick sold 22,337 shares at $5.61 per share on May 20 ’24. Company shares held by the EVP, CHIEF FINANCIAL OFFICER now total 116,829.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EDIT has a high of $11.69 and a low of $4.45.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EDIT’s latest balance sheet shows that the firm has $499.85M in Cash & Short Term Investments as of fiscal 2021. There were $26.38M in debt and $46.88M in liabilities at the time. Its Book Value Per Share was $3.58, while its Total Shareholder’s Equity was $553.64M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EDIT is Buy with a score of 3.88.

Most Popular

Related Posts